Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications

BACKGROUND: Recombinant human (rh)IGF-1/IGFBP-3 protein complex, administered as a continuous intravenous infusion in preterm infants, is being studied for the prevention of complications of prematurity. METHODS: We conducted in vitro studies to evaluate the physical and chemical compatibility of rh...

Descripción completa

Detalles Bibliográficos
Autores principales: Salamat-Miller, Nazila, Turner, Mark A., Bandekar, Amey, Dixit, Nitin, Jochim, Emily, Mangum, Barry, McPherson, Christopher, Tenjarla, Srini, Singh, Sukhjeet, Hwang, You Seok, Barton, Norman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832074/
https://www.ncbi.nlm.nih.gov/pubmed/36344872
http://dx.doi.org/10.1007/s12519-022-00610-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832074/
https://www.ncbi.nlm.nih.gov/pubmed/36344872
http://dx.doi.org/10.1007/s12519-022-00610-9

Ejemplares similares